<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00513565</url>
  </required_header>
  <id_info>
    <org_study_id>CRS105510</org_study_id>
    <nct_id>NCT00513565</nct_id>
  </id_info>
  <brief_title>A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers</brief_title>
  <official_title>A Randomised, Placebo-controlled, Double-dummy, Crossover Design Study to Investigate the Changes of fMRI BOLD Activation Induced by Emotional Activation Paradigms Following Single Doses of GSK561679 and Lorazepam (Comparator) in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted in healthy volunteers to investigate the effect of single dose
      GSK561679 on the changes of brain activation, as it compares to an active comparator,
      lorazepam.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 13, 2007</start_date>
  <completion_date type="Actual">May 14, 2009</completion_date>
  <primary_completion_date type="Actual">May 14, 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in fMRI brain activation (BOLD) response in specific brain regions</measure>
    <time_frame>conducted the duration of the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiologic changes</measure>
    <time_frame>during &amp; after fMRI session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale measurement of physical reactions</measure>
    <time_frame>duration of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood level of GSK561679</measure>
    <time_frame>collected during fMRI session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs &amp; ECG recording</measure>
    <time_frame>duration of the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lab tests for blood &amp; urine</measure>
    <time_frame>throughout the study</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Depressive Disorder and Anxiety Disorders</condition>
  <arm_group>
    <arm_group_label>placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>There are single dose treatment arms of GSK561679, lorazepam as well as placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GSK561679 arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are single dose treatment arms of GSK561679, lorazepam as well as placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lorazepam arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There are single dose treatment arms of GSK561679, lorazepam as well as placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>single dose</intervention_name>
    <description>Subjects will receive single doses of GSK561679, lorazepam, or placebo at each treatment session.</description>
    <arm_group_label>lorazepam arm</arm_group_label>
    <arm_group_label>placebo arm</arm_group_label>
    <arm_group_label>GSK561679 arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males

          -  Non-smokers

          -  Body weight 50 kg (110 lbs) or higher, and BMI within the range 19-29.9 kg/m2

          -  Normal ECG.

        Exclusion Criteria:

          -  Any serious medical disorder or condition.

          -  Any history of an endocrine disorder.

          -  Any clinically significant laboratory abnormality.

          -  History of psychiatric illness.

          -  Any history of suicidal attempts or behavior.

          -  History or current diagnosis of acute narrow angle glaucoma.

          -  Left handed
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://gsk-clinicalstudyregister.com/study/CRS105510?search=study&amp;study_ids=CRS105510#rs</url>
    <description>Results for study CRS105510 can be found on the GSK Clinical Study Register.</description>
  </link>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2007</study_first_submitted>
  <study_first_submitted_qc>August 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2007</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GSK561679,</keyword>
  <keyword>single,</keyword>
  <keyword>dose,</keyword>
  <keyword>lorazepam,</keyword>
  <keyword>fMRI,</keyword>
  <keyword>BOLD,</keyword>
  <keyword>healthy volunteers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lorazepam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

